Abstract
The purpose of the study is to evaluate the effectiveness and safety of transarterial chemoembolization (TACE) with pingyangmycin-lipiodol emulsion for the treatment of symptomatic giant hepatic haemangioma. Four hospitals (The Second Hospital of Shandong University, Qilu Hospital of Shandong University, Shandong Provincial Hospital and Jinan Municipal Hospital) participated in this study during 2002–2012. A total of 836 patients with symptomatic giant haemangioma were treated with pingyangmycin-lipiodol emulsion via selective TACE. The patients were followed-up for 12 months–10 years. The effectiveness of the treatment was evaluated by symptom assessments and upper abdominal magnetic resonance imaging or computed tomography. TACE was successfully performed for a total of 1120 lesions in 836 patients. Success rate of the procedure was 100 %. The mean diameter of the haemangiomas was significantly reduced after the interventional therapy (mean diameter 9.6 ± 0.8 vs. 3.6 ± 0.5 cm; P < 0.05). Symptom relief was achieved in all the patients during the follow-up period. No mortality was identified. TACE with pingyangmycin-lipiodol emulsion is a safe, feasible, and effective treatment for the giant symptomatic hepatic haemangioma.
Similar content being viewed by others
References
Feldman, M. (1958). Hemangioma of the liver. American Journal of Clinical Pathology, 29, 160–162.
Gandolfi, L., Leo, P., Solmi, L., et al. (1991). Natural history of hepatic haemangiomas: Clinical and ultrasound study. Gut, 32, 677–680.
Adam, Y. G., Huvos, A. G., & Fortner, J. G. (1970). Giant hemangiomas of the liver. Annals of Surgery, 172, 239–245.
Yamamoto, T., Kawarada, Y., Yano, T., Noguchi, T., et al. (1991). Spontaneous rupture of hemangioma of the liver: Treatment with transcatheter hepatic arterial embolization. The American Journal of Gastroenterology, 86, 1645–1649.
Takahashi, T., Katoh, H., Dohke, M., et al. (1997). A giant hepatic hemangioma with secondary portal hypertension: A case report of successful surgical treatment. Hepatogastroenterology, 44, 1212–1214.
Clarke, D., Currie, E., Madhavan, K., et al. (2004). Hepatic resection for benign non-cystic liver lesions. HPB (Oxford), 6, 115–119.
Charny, C. K., Jarnagin, W. R., Schwartz, L. H., et al. (2001). Management of 155 patients with benign liver tumors. British Journal of Surgery, 88(6), 808–813.
Tilborga, A., Nielsenb, K., Scheffera, H., et al. (2013). Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: Initial clinical experience. Clinical Radiology, 68, e9–e14.
Gaspar, L., Mascarenhas, F., da Costa, M. S., et al. (1993). Radiation therapy in the unresectable cavernous hemangioma of the liver. Radiotherapy and Oncology, 29(1), 45–50.
Althaus, S., Ashdown, B., Coldwell, D., et al. (1996). Transcatheter arterial embolization of two symptomatic giant cavernous hemangiomas of the liver. Cardiovascular and Interventional Radiology, 19, 364–367.
Giavroglou, C., Economou, H., & Ioannidis, I. (2003). Arterial embolization of giant hepatic hemangiomas. Cardiovascular and Interventional Radiology, 26, 92–96.
Bozkaya, H., Cinar, C., Besir, F. H., et al. (2014). Minimally invasive treatment of giant haemangiomas of the liver: Embolisation with bleomycin. Cardiovascular and Interventional Radiology, 37(1), 101–107.
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., et al. (2000). New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92(3), 205–216.
Tait, N., Richardson, A. J., Muguti, G., et al. (1992). Hepatic cavernous haemangioma: A 10 year review. Australian and New Zealand Journal of Surgery, 62, 521–524.
Terkivatan, T., Vrijland, W. W., Den Hoed, P. T., et al. (2002). Size of lesion is not a criterion for resection during management of giant liver haemangioma. British Journal of Surgery, 89, 1240–1244.
Gupta, S., Agarwal, V., & Acharya, A. N. (2012). Spontaneous rupture of a giant hepatic hemangioma-report of a case. Indian Journal of Surgery, 74(5), 434–436.
Wang, Z., Yuan, Y., Zhuang, H., et al. (2012). Hepatic haemangiomas: Possible association with IL-17. Journal of Clinical Pathology, 65(2), 146–151.
Glinkova, V., Shevah, O., Boaz, M., et al. (2004). Hepatic haemangiomas: Possible association with female sex hormones. Gut, 53, 1352–1355.
Ouyang, Y., Wang, Y., Ouyang, X. H., et al. (2004). Controversy and discussion on blood supply and interventional therapy of cavernous of hemangioma of the liver. Chinese Journal of Radiology, 38(7), 746–750. (in Chinese).
Herman, P., Costa, M. L., Machado, M. A., et al. (2005). Management of hepatic hemangiomas: A 14-year experience. Journal of Gastrointestinal Surgery, 9(6), 853–859.
Charny, C. K., Jarnagin, W. R., Schwartz, L. H., et al. (2001). Management of 155 patients with benign liver tumours. British Journal of Surgery, 88, 808–813.
Singh, R. K., Kapoor, S., Sahni, P., et al. (2007). Giant haemangioma of the liver: Is enucleation better than resection? Annals of the Royal College of Surgeons of England, 89(5), 490–493.
Ho, H. Y., Wu, T. H., Yu, M. C., et al. (2012). Surgical management of giant hepatic hemangiomas: Complications and review of the literature. Chang Gung Medical Journal, 35(1), 70–78.
Deutsch, G. S., Yeh, K. A., Bates, W. B, 3rd, et al. (2001). Embolization for management of hepatic hemangiomas. The American Surgeon, 67(2), 159–164.
Jia, Y., Jia, J., & Zhao, Y. (2012). Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells. Journal of Huazhong University of Science and Technology [Medical Sciences], 32(5), 760–766.
Liu, X., Luo, X. P., Cao, W. T., et al. (2012). Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits. Zhonghua Gan Zang Bing Za zhi= Zhonghua Ganzangbing Zazhi= Chinese Journal of Hepatology, 20(8), 611–616. (in Chinese).
Author information
Authors and Affiliations
Corresponding author
Additional information
Yuliang Li and Yunming Jia have contributed equally to this study.
Rights and permissions
About this article
Cite this article
Li, Y., Jia, Y., Li, S. et al. Transarterial Chemoembolization of Giant Liver Haemangioma: A Multi-center Study with 836 Cases. Cell Biochem Biophys 73, 469–472 (2015). https://doi.org/10.1007/s12013-015-0680-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0680-y